100 related articles for article (PubMed ID: 17483364)
1. Divergent mechanisms of glucocorticoid resistance in experimental models of pediatric acute lymphoblastic leukemia.
Bachmann PS; Gorman R; Papa RA; Bardell JE; Ford J; Kees UR; Marshall GM; Lock RB
Cancer Res; 2007 May; 67(9):4482-90. PubMed ID: 17483364
[TBL] [Abstract][Full Text] [Related]
2. Reversal of glucocorticoid resistance in paediatric acute lymphoblastic leukaemia is dependent on restoring BIM expression.
Toscan CE; Jing D; Mayoh C; Lock RB
Br J Cancer; 2020 Jun; 122(12):1769-1781. PubMed ID: 32242100
[TBL] [Abstract][Full Text] [Related]
3. Synergistic combination of isogarcinol isolated from edible fruits of Garcinia multiflora and dexamethasone to overcome leukemia glucocorticoid resistance.
Liu Q; Niu ZP; Yang K; Song JR; Wei XN; Huang YB; Yuan CM; Li YM
Biomed Pharmacother; 2024 Jan; 170():115936. PubMed ID: 38039755
[TBL] [Abstract][Full Text] [Related]
4. ESRRB regulates glucocorticoid gene expression in mice and patients with acute lymphoblastic leukemia.
Gallagher KM; Roderick JE; Tan SH; Tan TK; Murphy L; Yu J; Li R; O'Connor KW; Zhu J; Green MR; Sanda T; Kelliher MA
Blood Adv; 2020 Jul; 4(13):3154-3168. PubMed ID: 32658986
[TBL] [Abstract][Full Text] [Related]
5. Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model.
Jones CL; Bhatla T; Blum R; Wang J; Paugh SW; Wen X; Bourgeois W; Bitterman DS; Raetz EA; Morrison DJ; Teachey DT; Evans WE; Garabedian MJ; Carroll WL
J Biol Chem; 2014 Jul; 289(30):20502-15. PubMed ID: 24895125
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 stimulates cAMP signaling and resensitizes human leukemia cells to glucocorticoid-induced cell death.
Roderick JE; Gallagher KM; Murphy LC; O'Connor KW; Tang K; Zhang B; Brehm MA; Greiner DL; Yu J; Zhu LJ; Green MR; Kelliher MA
Blood; 2021 Jan; 137(4):500-512. PubMed ID: 33507291
[TBL] [Abstract][Full Text] [Related]
7. Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia.
Wandler AM; Huang BJ; Craig JW; Hayes K; Yan H; Meyer LK; Scacchetti A; Monsalve G; Dail M; Li Q; Wong JC; Weinberg O; Hasserjian RP; Kogan SC; Jonsson P; Yamamoto K; Sampath D; Nakitandwe J; Downing JR; Zhang J; Aster JC; Taylor BS; Shannon K
Leukemia; 2020 Aug; 34(8):2025-2037. PubMed ID: 32066867
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of Musashi-2 exerts antileukemic effects on acute lymphoblastic leukemia cells and increases sensitivity to dexamethasone.
Zou D; Lv M; Chen Y; Niu T; Ma C; Shi C; Huang Z; Wu Y; Yang S; Wang Y; Wu N; Zhang Y; Ouyang G; Mu Q
Ann Hematol; 2024 Jan; 103(1):141-151. PubMed ID: 37749318
[TBL] [Abstract][Full Text] [Related]
9. The arginine metabolome in acute lymphoblastic leukemia can be targeted by the pegylated-recombinant arginase I BCT-100.
De Santo C; Booth S; Vardon A; Cousins A; Tubb V; Perry T; Noyvert B; Beggs A; Ng M; Halsey C; Kearns P; Cheng P; Mussai F
Int J Cancer; 2018 Apr; 142(7):1490-1502. PubMed ID: 29168171
[TBL] [Abstract][Full Text] [Related]
10. Integrative genomic analyses reveal mechanisms of glucocorticoid resistance in acute lymphoblastic leukemia.
Autry RJ; Paugh SW; Carter R; Shi L; Liu J; Ferguson DC; Lau CE; Bonten EJ; Yang W; McCorkle JR; Beard JA; Panetta JC; Diedrich JD; Crews KR; Pei D; Coke CJ; Natarajan S; Khatamian A; Karol SE; Lopez-Lopez E; Diouf B; Smith C; Gocho Y; Hagiwara K; Roberts KG; Pounds S; Kornblau SM; Stock W; Paietta EM; Litzow MR; Inaba H; Mullighan CG; Jeha S; Pui CH; Cheng C; Savic D; Yu J; Gawad C; Relling MV; Yang JJ; Evans WE
Nat Cancer; 2020 Mar; 1(3):329-344. PubMed ID: 32885175
[TBL] [Abstract][Full Text] [Related]
11. Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells.
Jing D; Bhadri VA; Beck D; Thoms JA; Yakob NA; Wong JW; Knezevic K; Pimanda JE; Lock RB
Blood; 2015 Jan; 125(2):273-83. PubMed ID: 25336632
[TBL] [Abstract][Full Text] [Related]
12. PAX5 is a tumor suppressor in mouse mutagenesis models of acute lymphoblastic leukemia.
Dang J; Wei L; de Ridder J; Su X; Rust AG; Roberts KG; Payne-Turner D; Cheng J; Ma J; Qu C; Wu G; Song G; Huether RG; Schulman B; Janke L; Zhang J; Downing JR; van der Weyden L; Adams DJ; Mullighan CG
Blood; 2015 Jun; 125(23):3609-17. PubMed ID: 25855603
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition.
Bachmann PS; Piazza RG; Janes ME; Wong NC; Davies C; Mogavero A; Bhadri VA; Szymanska B; Geninson G; Magistroni V; Cazzaniga G; Biondi A; Miranda-Saavedra D; Göttgens B; Saffery R; Craig JM; Marshall GM; Gambacorti-Passerini C; Pimanda JE; Lock RB
Blood; 2010 Oct; 116(16):3013-22. PubMed ID: 20647567
[TBL] [Abstract][Full Text] [Related]
14. Comparison of high-throughput single-cell RNA-seq methods for ex vivo drug screening.
Gezelius H; Enblad AP; Lundmark A; Åberg M; Blom K; Rudfeldt J; Raine A; Harila A; Rendo V; Heinäniemi M; Andersson C; Nordlund J
NAR Genom Bioinform; 2024 Mar; 6(1):lqae001. PubMed ID: 38288374
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between glucocorticoid and mineralocorticoid receptors boosts glucocorticoid-induced killing of multiple myeloma cells.
Clarisse D; Prekovic S; Vlummens P; Staessens E; Van Wesemael K; Thommis J; Fijalkowska D; Acke G; Zwart W; Beck IM; Offner F; De Bosscher K
Cell Mol Life Sci; 2023 Aug; 80(9):249. PubMed ID: 37578563
[TBL] [Abstract][Full Text] [Related]
16. Beyond Corticoresistance, A Paradoxical Corticosensitivity Induced by Corticosteroid Therapy in Pediatric Acute Lymphoblastic Leukemias.
Angot L; Schneider P; Vannier JP; Abdoul-Azize S
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345151
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone-Induced Fatty Acid Oxidation and Autophagy/Mitophagy Are Essential for T-ALL Glucocorticoid Resistance.
Olivas-Aguirre M; Pérez-Chávez J; Torres-López L; Hernández-Cruz A; Pottosin I; Dobrovinskaya O
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672393
[TBL] [Abstract][Full Text] [Related]
18. LRH-1/NR5A2 interacts with the glucocorticoid receptor to regulate glucocorticoid resistance.
Michalek S; Goj T; Plazzo AP; Marovca B; Bornhauser B; Brunner T
EMBO Rep; 2022 Sep; 23(9):e54195. PubMed ID: 35801407
[TBL] [Abstract][Full Text] [Related]
19. STAT5 does not drive steroid resistance in T-cell acute lymphoblastic leukemia despite the activation of
Van der Zwet JCG; Cordo' V; Buijs-Gladdines JGCAM; Hagelaar R; Smits WK; Vroegindeweij E; Graus LTM; Poort V; Nulle M; Pieters R; Meijerink JPP
Haematologica; 2023 Mar; 108(3):732-746. PubMed ID: 35734930
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms contributing to glucocorticoid resistance in lymphoid malignancies.
Scheijen B
Cancer Drug Resist; 2019; 2(3):647-664. PubMed ID: 35582582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
